← All news

FROM THE NEWS FEED

Compass announces promising yet modest results from second Phase 3 psilocybin trial; Missouri hearings on ibogaine and psilocybin bills, New Hampshire psilocybin bill advances

2026-02-20 • The Microdose (Berkeley)

Article summary

Plus: Helus’s DMT formulation shows promise in treating depression and Compass laying groundwork for COMP360 trigger law in Vermont

Continue to the original publication for the complete article.